This article summarizes recent analyst ratings for several NASDAQ-listed stocks, including Akero Therapeutics, Alumis, Amneal Pharmaceuticals, BRP Inc., Amplitude, and SoundHound AI. Read more...

Recent analyst reports show optimism for several companies, including Apogee Therapeutics, Avadel Pharmaceuticals, and Nvidia, with potential upside for investors. Read more...

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB. Read more...

Analyst ratings shift for major companies like Disney and HP, while HPE reports impressive revenue growth despite cash flow concerns. Plus, updates on Installed Building Products, MeridianLink, and Sunrun. Read more...

A roundup of recent analyst ratings and price target adjustments for companies like NetApp, Lexicon Pharmaceuticals, Medpace Holdings, and more. Plus, a look at Nvidia vs. Broadcom in the AI space. Read more...

Recent financial news includes Magnolia Private Wealth acquiring a stake in Meta, analysts rating MarketAxess "Hold," and Mizuho forecasting upside for PENN Entertainment. Read more...

Several stocks have seen recent target price adjustments by analysts. This article summarizes the latest ratings and price target changes for Owens Corning, AES, ON, Fulgent Genetics, and Rexford Industrial Realty. Read more...

A look at recent stock movements in the tech and medical sectors, highlighting insider buying in Sunrun, a price target reduction for GigaCloud, and disappointing earnings from Syndax. Read more...

Nordstrom reports better-than-expected earnings in Q4 2024 and receives a "Market Perform" rating as it prepares to go private, marking a pivotal moment in the company's history. Read more...

Recent analyst reports show positive momentum for YETI, ON Semiconductor, and Eli Lilly, with raised price targets and continued "overweight" ratings. Plus, a look at Caterpillar as a potential dividend stock. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...

Mutual of America Capital Management adjusted its holdings in Cincinnati Financial and Expedia Group, while Barclays raised Okta's price target and ASML Holding saw a drop in short interest. Read more...

Okta (OKTA) receives multiple analyst upgrades and price target increases from firms like KeyCorp, DA Davidson, Mizuho, and Goldman Sachs, signaling strong market confidence. Read more...

AST SpaceMobile stock experiences both surges and drops, fueled by partnerships, analyst ratings, and even presidential comments, making it a volatile investment. Read more...

Oracle enjoys a record-breaking year with a UK sales milestone and reaffirmed "buy" ratings from analysts. Plus, insights into Warren Buffett's investment strategy. Read more...